EPHA3 encodes a protein tyrosine kinase receptor and its expression has been associated with high invasive capacity and poor overall survival in hepatocellular carcinoma, gastric cancer, and glioblastoma [40–42]. The gene discussed is EPHA3; the disease is hepatocellular carcinoma.